胰島素幫浦市場規模、佔有率和成長分析：按類型、組件、疾病、治療方法、應用、患者群體、分銷管道和地區分類－2026年至2033年產業預測

2024 年全球胰島素幫浦市場價值為 60.5 億美元，預計到 2025 年將成長至 65.5 億美元，到 2033 年將成長至 123.2 億美元，在預測期（2026-2033 年）內複合年成長率為 8.22%。

全球胰島素幫浦市場正經歷顯著成長，這主要得益於糖尿病（尤其是第1型糖尿病）盛行率的不斷上升以及人們對有效管理方法的日益關注。隨著越來越多的人尋求攜帶式胰島素輸註解決方案，該行業也在不斷調整以滿足不斷變化的消費者需求。推動這一成長的關鍵因素包括技術進步，例如將人工智慧 (AI) 和機器學習技術整合到胰島素幫浦中，從而提升其功能和效率。醫療保健成本的上升和醫療資源的可近性提高也進一步刺激了市場需求。由於糖尿病可能導致嚴重的併發症，因此對創新胰島素輸注系統的需求至關重要，這使得胰島素幫浦市場成為眾多醫療保健領域的重要組成部分。

全球胰島素幫浦市場的成長要素

全球胰島素幫浦市場正經歷顯著成長，這主要得益於領先企業專注於創新技術研發和新產品上市。這一快速成長主要歸功於已開發市場和新興市場糖尿病患者對胰島素幫浦的接受度不斷提高。此外，大量臨床試驗表明，與使用每日多次注射（MDI）療法的患者相比，胰島素幫浦療法在改善第二型糖尿病患者的血糖控制方面更為有效。這些技術進步和患者療效的提升正在推動市場發展，並為行業相關人員創造新的機會。

全球胰島素幫浦市場的限制因素

全球胰島素幫浦市場面臨的一大挑戰是，許多患者依賴保險報銷來獲得所需的治療。有限的保險覆蓋範圍和胰島素幫浦的高昂費用阻礙了許多患者使用這項技術。這種經濟障礙可能會阻礙胰島素幫浦的廣泛應用，並抑制全球胰島素幫浦市場的成長和發展。由於醫療費用承擔能力仍然是獲得醫療服務的關鍵因素，因此，難以確保充足的保險報銷可能會影響患者投資購買胰島素幫浦以滿足其治療需求的意願。

全球胰島素幫浦市場趨勢

全球胰島素幫浦市場正經歷一場動態變革，其驅動力在於智慧技術（尤其是人工智慧 (AI)）與糖尿病管理解決方案的整合。隨著全球 2 型糖尿病盛行率的持續上升，對具備高度自動化和個人化功能的先進胰島素輸注系統的需求日益成長。醫療設備製造商正積極掌握這一趨勢，開發人工智慧驅動的胰島素泵，以簡化血糖監測和胰島素輸注流程。預計對先進技術的日益依賴將顯著提升胰島素幫浦的普及率，反映出醫療保健領域正朝著更有效率、更有效的糖尿病照護解決方案邁進。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系圖譜
• 2025年市場魅力指數
• PESTLE分析
• 價值鏈分析
• 價格分析
• 案例研究
• 監理情勢
• 技術評估
• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系圖譜
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估

全球胰島素幫浦市場規模：依產品類型分類

• 胰島素幫浦
  • 有線泵
  • 貼片幫浦
  • 智慧胰島素泵
  • 其他
• 耗材和配件
  • 注射套裝
  • 水箱/墨盒
  • 其他

全球胰島素幫浦市場規模：依疾病適應症分類

• 1型糖尿病
• 2型糖尿病

全球胰島素幫浦市場規模：依治療方法分類

• 傳統治療方法
• 持續胰島素輸注
• 自動胰島素注射
• 混合封閉式系統

全球胰島素幫浦市場規模：按使用類型分類

• 可重複使用泵浦
• 一次性泵浦

全球胰島素幫浦市場規模：依患者群體分類

• 兒童（0-17歲）
• 成年人（18歲以上）
• 老年人（65歲以上）

全球胰島素幫浦市場規模：依最終用途分類

• 醫院和診所
• 居家照護
• 研究所

全球胰島素幫浦市場規模：按分銷管道分類

• 醫院藥房
• 零售藥房
• 網路藥房
• 直銷

全球胰島素幫浦市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Ypsomed
• Hoffmann-La Roche AG
• Sanofi SA
• Sooil Development Co. Ltd.
• Beta Bionics Inc.
• Cellnovo Ltd
• B. Braun Melsungen AG
• ViCentra BV
• Jiangsu Delfu Co., Ltd.
• Debiotech SA
• Medtrum Technologies
• MicroTech Medical
• Sequel Med Tech, LLC
• PharmaSens

美納里尼診斷

• 公司簡介
• 業務部門概覽
• 財務資訊
• 主要趨勢
• 拜耳糖尿病護理
  • 公司簡介
  • 業務部門概覽
  • 財務資訊
  • 主要趨勢
• EverSense（Sensonics）
  • 公司簡介
  • 業務部門概覽
  • 財務資訊
  • 主要趨勢

結論與建議

Global Insulin Pump Market size was valued at USD 6.05 Billion in 2024 and is poised to grow from USD 6.55 Billion in 2025 to USD 12.32 Billion by 2033, growing at a CAGR of 8.22% during the forecast period (2026-2033).

The global market for insulin pumps is experiencing significant expansion, driven by an increasing prevalence of diabetes, notably type 1 diabetes, along with a heightened awareness of effective management options. As more individuals seek portable insulin delivery solutions, the industry has adapted to meet evolving consumer needs. Key contributors to this growth include advancements in technology, such as the integration of artificial intelligence and machine learning into insulin pumps, enhancing their functionality and efficiency. Rising healthcare expenditures and improved access to medical resources have further fueled market demand. With diabetes linked to serious complications, there is a pressing need for innovative insulin delivery systems, making the insulin pump market a critical area within the broader healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pump Market Segments Analysis

Global Insulin Pumps Market is segmented by Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel and region. Based on Type, the market is segmented into Tethered Insulin Pumps, Patch Pumps (Tubeless Pumps), Miniature/Implantable Pumps and Smart Insulin Pumps. Based on Component, the market is segmented into Pump Device, Infusion Set (Cannula & Tubing), Reservoir or Cartridge, Battery and Power Systems and Control System & Software. Based on Disease Indication, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on Type of Therapy, the market is segmented into Conventional Insulin Therapy, Continuous Subcutaneous Insulin Infusion (CSII), Automated Insulin Delivery (AID) or Closed Loop Systems and Hybrid Closed Loop Systems. Based on Usage Type, the market is segmented into Reusable Insulin Pumps and Disposable Insulin Pumps. Based on Patient Demographics, the market is segmented into Pediatric (0-17 years), Adult (18+ years) and Geriatric (65+ years). Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Direct Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Pump Market

The Global Insulin Pump market is witnessing significant growth driven by key players focusing on research and development of innovative technologies and the introduction of new products. This surge is largely attributed to the increasing adoption of insulin pumps by diabetic patients in both developed and emerging markets. Additionally, numerous clinical trials demonstrate the effectiveness of pump therapy in enhancing glucose control for type 2 diabetes patients compared to those utilizing Multiple Daily Injection (MDI) therapy. These advancements in technology and improvements in patient outcomes are propelling the market forward, creating new opportunities for stakeholders in the industry.

Restraints in the Global Insulin Pump Market

A significant challenge facing the global insulin pump market is the reliance of numerous patients on reimbursement options to afford necessary treatments for their conditions. The limited availability of reimbursement and the high expenses associated with insulin pumps discourage many individuals from utilizing this technology. This financial barrier presents an obstacle to broader adoption, potentially hindering the growth and development of the insulin pump market on a global scale. As affordability remains a crucial factor in healthcare access, the struggle to secure adequate reimbursement options may impact the willingness of patients to invest in insulin pumps for their management needs.

Market Trends of the Global Insulin Pump Market

The Global Insulin Pump market is experiencing a dynamic transformation fueled by the integration of intelligent technologies, particularly artificial intelligence, into diabetes management solutions. As the prevalence of type 2 diabetes continues to rise globally, there is an escalating demand for sophisticated insulin delivery systems that offer enhanced automation and personalization. Medical device manufacturers are poised to leverage this trend, developing AI-enabled pumps that streamline glucose monitoring and insulin delivery. This increasing reliance on advanced technologies is projected to significantly boost the adoption rates of insulin pumps, reflecting a broader shift towards more efficient and effective diabetes care solutions in the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment
• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment

Global Insulin Pump Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Insulin Pumps
  • Tethered Pumps
  • Patch Pumps
  • Smart Insulin Pumps
  • Others
• Consumables & Accessories
  • Infusion Sets
  • Reservoirs/Cartridges
  • Others

Global Insulin Pump Market Size by Disease Indication & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Pump Market Size by Therapy Type & CAGR (2026-2033)

• Market Overview
• Conventional Therapy
• Continuous Insulin Infusion
• Automated Insulin Delivery
• Hybrid Closed Loop Systems

Global Insulin Pump Market Size by Usage Type & CAGR (2026-2033)

• Market Overview
• Reusable Pumps
• Disposable Pumps

Global Insulin Pump Market Size by Patient Demographics & CAGR (2026-2033)

• Market Overview
• Pediatric (0-17 Years)
• Adult (18+ Years)
• Geriatric (65+ Years)

Global Insulin Pump Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Homecare
• Laboratories

Global Insulin Pump Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Direct Sales

Global Insulin Pump Market Size & CAGR (2026-2033)

• North America (Product Type, Disease Indication, Therapy Type, Usage Type, Patient Demographics, End Use, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Disease Indication, Therapy Type, Usage Type, Patient Demographics, End Use, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Disease Indication, Therapy Type, Usage Type, Patient Demographics, End Use, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Disease Indication, Therapy Type, Usage Type, Patient Demographics, End Use, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Disease Indication, Therapy Type, Usage Type, Patient Demographics, End Use, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sooil Development Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beta Bionics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellnovo Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViCentra B.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Delfu Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Debiotech S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtrum Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTech Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sequel Med Tech, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaSens
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Menarini Diagnostics

• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Bayer Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eversense (Senseonics)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations